Zygj van Lierop

9PUBLICATIONS
19CO-AUTHORS
Cellular nervous systemNeurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 18, 2024
Impact of serum neurofilament light on clinical decisions in a tertiary multiple sclerosis clinic.

Zoë Ygj van Lierop, Mark Hj Wessels, Womei Ml Lekranty

|Aug 02, 2023
Serum glial fibrillary acidic protein in natalizumab-treated relapsing-remitting multiple sclerosis: An alternative to neurofilament light.

Mark Hj Wessels, Zoë Ygj Van Lierop, Samantha Noteboom

|Sep 05, 2022
Neurofilament-light and contactin-1 association with long-term brain atrophy in natalizumab-treated relapsing-remitting multiple sclerosis.

Zoë Ygj van Lierop, Samantha Noteboom, Martijn D Steenwijk

|Mar 25, 2022
Pre-analytical stability of serum biomarkers for neurological disease: neurofilament-light, glial fibrillary acidic protein and contactin-1.

Zoë Y G J van Lierop, Inge M W Verberk, Kees W J van Uffelen

|Sep 10, 2021
Serum Neurofilament Light Association With Progression in Natalizumab-Treated Patients With Relapsing-Remitting Multiple Sclerosis.

Claire Bridel, Cyra E Leurs, Zoë Y G J van Lierop

|Jul 09, 2021
Personalized B-cell tailored dosing of ocrelizumab in patients with multiple sclerosis during the COVID-19 pandemic.

Zoë Ygj van Lierop, Alyssa A Toorop, Wouter Jc van Ballegoij

Pageof 2

Frequent Collaborators

4 joint publications

Frederik Barkhof

3 joint publications

Eva Mm Strijbis

3 joint publications

Zoé LE Van Kempen

2 joint publications

Charlotte E Teunissen